Dr. Yuguang Shi's lab at the University of Texas Health Science Center focuses on understanding how obesity leads to chronic inflammation, which is linked to metabolic diseases like insulin resistance. They specifically investigate a protein called ALCAT1 and its role in activating inflammation in fat tissue when faced with dietary challenges. This research could reveal new ways to treat obesity and related metabolic conditions by targeting ALCAT1.

The lab led by Adam Salmon at the University of Texas Health Science Center focuses on researching potential anti-aging therapies through the testing of small molecules in mice. By examining how these treatments can extend the lifespan and improve health conditions associated with aging, their goal is to find effective interventions that could eventually benefit human longevity. This work is part of a larger collaborative program that not only evaluates drug effects but also contributes essential data and tissues to the scientific community.

Dr. William P. Clarke's lab focuses on developing new pain relief medications that are safer than current opioid drugs. By studying the combination of specific opioid receptors in pain-sensing neurons, the lab aims to create drugs that effectively reduce pain without the dangerous side effects associated with traditional opioids. Their research combines chemistry, pharmacology, and biotechnology to discover and test novel drug candidates.